SMU-L11
Based on 1 Customer Validation
SMU-L11 is a specific TLR7 agonist (EC50=0.024 μM), which recruits MyD88 adapter protein and activates downstream NF-κB and MAPK signaling pathways. In murine models, SMU-L11 significantly enhances immune cell activation and promotes the proliferation of CD4+ T and CD8+ T cells, thereby directly killing tumor cells and inhibiting tumor growth. SMU-L11 can be used for cancer research, and also has the potential for studying immune system diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.64%
- CAS. Nr.: 3029695-07-3
- Formel: C19H24N4O
- Molecular Weight:324.42
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
TLR7 0.024 μM (EC50) |
Chemical Information
-
CAS. Nr. 3029695-07-3
-
Appearance Solid
-
Molecular Weight 324.42
-
Formel C19H24N4O
-
Color White to off-white
-
SMILES
CCCCC1=NC2=C(N1CC3CCOC3)C4=CC=CC=C4N=C2N
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- SMU-L11
- 3029695-07-3
- Toll-like Receptor (TLR)
- NF-κB
- MAPKAPK2 (MK2)
- Nuclear factor-κB
- Nuclear factor-kappaB
- Mitogen-activated protein kinase activated protein kinase 2
- MAP kinase activated protein kinase 2
- MAPK activated protein kinase 2
- MAPKAP kinase 2
- cancer
- tumor
- MAPK
- CD4+ T
- CD8+ T
- immune
- macrophages
- Inhibitor
- inhibitor
- inhibit